What are the first-line antibiotics for uncomplicated urinary tract infections (UTIs) in both men and women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Antibiotics for Uncomplicated UTI

For women with uncomplicated cystitis, use nitrofurantoin (100 mg twice daily for 5 days), fosfomycin trometamol (3 g single dose), or pivmecillinam (400 mg three times daily for 3-5 days) as first-line therapy; for men, use trimethoprim-sulfamethoxazole (160/800 mg twice daily for 7 days) as first-line treatment. 1

Treatment for Women

First-Line Options

The 2024 European Association of Urology guidelines establish clear first-line agents for women with uncomplicated cystitis:

  • Fosfomycin trometamol: 3 g single dose (1 day) 1, 2
  • Nitrofurantoin: Multiple formulations available 1, 3
    • Macrocrystals: 50-100 mg four times daily for 5 days
    • Monohydrate or macrocrystals: 100 mg twice daily for 5 days
    • Prolonged release: 100 mg twice daily for 5 days
  • Pivmecillinam: 400 mg three times daily for 3-5 days (where available) 1, 3

These agents are preferred because they demonstrate equivalent efficacy to broader-spectrum antibiotics while minimizing collateral damage to normal flora and reducing resistance development. 4, 5

Alternative Options (When First-Line Agents Cannot Be Used)

  • Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 3 days—only if local E. coli resistance is <20% 1, 3
  • Trimethoprim alone: 200 mg twice daily for 5 days (avoid in first trimester of pregnancy) 1
  • Cephalosporins (e.g., cefadroxil): 500 mg twice daily for 3 days—only if local E. coli resistance is <20% 1, 3

Critical caveat: Fluoroquinolones should be reserved for more invasive infections due to their propensity for ecological adverse effects and resistance development, despite high efficacy. 6 Amoxicillin and ampicillin should not be used empirically due to high resistance rates. 3

Treatment for Men

Men with uncomplicated UTI require longer treatment duration (7 days) compared to women. 1

First-Line Option

  • Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 7 days 1
  • Fluoroquinolones can be prescribed according to local susceptibility testing 1

Alternative Options

  • Trimethoprim: 7-day course 7
  • Nitrofurantoin: 7-day course 7

Important consideration: Always obtain urine culture in men before initiating treatment, as UTIs in men warrant investigation for underlying urologic abnormalities or prostatitis. 7 The longer treatment duration (7 days vs. 3-5 days in women) accounts for potential prostatic involvement even in apparently uncomplicated cases. 7

Key Clinical Decision Points

When to Obtain Urine Culture Before Treatment

Urine culture is recommended in these specific situations: 1, 3

  • Suspected acute pyelonephritis
  • Symptoms that do not resolve or recur within 4 weeks after treatment completion
  • Women presenting with atypical symptoms
  • Pregnant women
  • All men with UTI symptoms 7

Pregnancy Considerations

  • Avoid trimethoprim in the first trimester 1, 3
  • Avoid trimethoprim-sulfamethoxazole in the last trimester 1, 3
  • Preferred agents include cephalosporins (e.g., cefuroxime) or nitrofurantoin 8

Treatment Failure Management

If symptoms do not resolve by the end of treatment or recur within 2 weeks: 1, 3

  • Obtain urine culture and antimicrobial susceptibility testing
  • Assume the infecting organism is not susceptible to the original agent
  • Retreat with a 7-day regimen using a different antibiotic class

Non-Antimicrobial Option

For women with mild to moderate symptoms only, symptomatic therapy with ibuprofen may be considered as an alternative to immediate antimicrobial treatment after shared decision-making with the patient. 1, 3 However, this approach carries a low risk of progression and should be reserved for highly selected patients who understand the trade-offs. 7

Resistance Pattern Considerations

The choice of empirical therapy must account for local resistance patterns: 1, 3

  • Local resistance rates should be <10% for pyelonephritis and <20% for lower UTI treatment 1
  • Trimethoprim-sulfamethoxazole and fluoroquinolones have high resistance rates in many communities, precluding their routine empiric use 4, 6
  • Nitrofurantoin, fosfomycin, and pivmecillinam maintain favorable resistance profiles globally 4, 5

Common Pitfalls to Avoid

  • Do not use routine post-treatment urinalysis or urine cultures in asymptomatic patients 1
  • Do not prescribe fluoroquinolones as first-line therapy for uncomplicated cystitis—reserve them for complicated infections or pyelonephritis 3, 6
  • Do not use beta-lactams (amoxicillin-clavulanate, cefpodoxime-proxetil) as first-line empirical therapy—they are less effective than other options 6
  • Do not treat men with the same short-course regimens used in women—men require 7 days minimum 1, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.